Human Fetus at 31 Weeks in the Womb (Caucasian Skin)

Description

At approximately 31 weeks of gestation the fetus lies in a flexed attitude within the amniotic cavity, head to the left and limbs drawn toward the trunk in the limited space of the third-trimester uterus. Surface detail is well developed: the auricle of the ear shows its definitive folds, fine scalp hair is present, the eyelids are closed, and subcutaneous fat has begun to smooth the contours of the cheeks, thorax and thighs. One hand rests against the face while the opposite arm extends upward, and the plantar surface of a foot is turned toward the viewer. The translucent amniotic membrane encloses the fetus and amniotic fluid, while the umbilical cord spirals from the abdominal insertion to a discoid placenta whose chorionic vessels branch visibly across its fetal surface against the vascular uterine wall. Week 31 sits within the period of rapid weight gain, brain growth and pulmonary maturation, when surfactant production is increasing but not yet complete. This is the anatomy behind third-trimester obstetric assessment: fundal height and estimated fetal weight, biophysical profile scoring of movement and tone, amniotic fluid index, and Doppler interrogation of umbilical artery flow. Placental position and cord insertion, both evident here, are central to counselling about placenta praevia, vasa praevia and cord accidents, while the flexed cephalic attitude relates directly to presentation, engagement and planning for preterm delivery and neonatal intensive care. The rendering suits antenatal education leaflets, midwifery and obstetric nursing curricula, pregnancy apps and week-by-week development series, alongside embryology and human development lectures. Publishers of parenting titles, ultrasound training providers and clinicians explaining fetal position, cord anatomy and placental function to expectant parents will find it directly usable, and it maintains visual continuity with the earlier gestational stages in this series. Anatomical accuracy verified by SciePro's Medical Advisory Board.